Research status of traditional Chinese medicine intervention in mTOR pathway targeting autophagy for prevention and treatment of diabetic nephropathy
10.13699/j.cnki.1001-6821.2024.11.029
- VernacularTitle:中医药干预mTOR通路靶向自噬防治糖尿病肾病的研究现状
- Author:
Shi-Rui YANG
1
;
Ting-Ting ZHOU
;
Chao-Chao MA
;
Peng-Fei YANG
;
Fan-Qi NIU
;
Xue-Yang DU
;
Feng-Zhe YAN
;
Si-Nong WANG
Author Information
1. 甘肃中医药大学中医临床学院,甘肃兰州 730000
- Keywords:
phosphoinositol 3 kinase/protein kinase B/mammalian rapamycin target pathway;
adenosine monophosphate-activated protein kinase/mammalian target of rapamycin signaling pathway;
autophagy;
diabetic kidney
- From:
The Chinese Journal of Clinical Pharmacology
2024;40(11):1675-1678
- CountryChina
- Language:Chinese
-
Abstract:
Diabetic kidney disease(DKD)is one of the most important complications of diabetes.In recent years,domestic and foreign studies have found that mammalian target protein of rapamycin(mTOR)related signaling pathway is a classic pathway involved in the regulation of autophagy,which can achieve the therapeutic effect of DKD by targeting the autophagy pathway,and plays a crucial role in the prevention and treatment of DKD.In this paper,we reviewed the mechanism of mTOR-related signaling pathway targeted autophagy in the prevention and treatment of DKD,in order to provide a new reference and basis for clinical prevention and treatment of DKD.